Lancet, NEJM Retract Covid-19 Studies
Studies of RAAS inhibitors, hydroxychloroquine withdrawn for lack of third-party validation In the...
Read More
BreakingMed
Covid-19: Hydroxychloroquine Flops as Postexposure Prophylactic
But last word not yet spoken Hydroxychloroquine is back in the news as another study, just...
Read More
ASCO: Breast Cancer Brain Mets Treated with Tucatinib
Addition of agent to chemotherapy improves survival The risk of death or progression of brain...
Read More
Add-On CTA Benefits Some—But Not All—with Stable Chest Pain
Across-the-board secondary coronary CT angiography not necessary in all cases of suspected stable...
Read More
Radiosurgery Alone Results in Encouraging Survival Outcomes for SCLC Patients with Brain Metastases
Absence of survival advantage and toxicity of whole brain radiotherapy makes SRS a good option for...
Read More
DBS with Novel Device Reduces Parkinson’s Symptoms
One-year INTREPID results show efficacy A deep brain stimulation system (DBS) with a novel device...
Read More
CMSC 2020: Trio of EXPAND Analyses Provides More Answers About Siponimod
Findings add to evidence of siponimod efficacy and safety A trio of papers based on deep dives...
Read More
Ixekizumab Garners FDA OK for TX of Non-Radiographic Axial Spondyloarthritis
Robust results of COAST-X trial prompted approval The FDA recently approved ixekizumab (Taltz) in...
Read More
CMSC 2020: Emerging Therapies Build on the Progress of the Past Decade
No slowing of MS therapeutic pipeline Available treatments for multiple sclerosis have increased...
Read More
CMSC 2020: Trio of EXPAND Analyses Provide More Answers About Siponimod
Findings add to evidence of siponimod efficacy and safety A trio of papers based on deep dives...
Read More
Blood Biomarkers May Inform Post-Concussion Prognosis
Exosomal and plasma NfL levels in military veterans linked to neurobehavioral symptoms Repetitive...
Read More
Rituximab Add on Prolongs Survival for Kids with NHL, But Causes Serious Side Effects
Rituximab added to chemotherapy led to a higher incidence of severe adverse events The addition of...
Read MoreSuicide, Gun Ownership Go Hand in Hand
Study: The risk of suicide is greatest in first 30 days after acquiring a gun Owning a gun greatly increases the risk that it will be used for suicide, according to a special report in The New England Journal of Medicine....
Read More
ASCO: Larotrectinib Produces Durable Responses
TRK fusion targets multiple cancers Patients diagnosed with a variety of advanced cancers —...
Read More
Successful Integration of Behavioral Health into Medical Practices Faces Many Hurdles
These include cultural, informational, and financial challenges While attempts to integrate...
Read More
Glucose-Lowering Rx Reduced Cardiovascular Events in Type 2 Diabetes
Modest weight loss with drugs or lifestyle changes reduced heart failure risk in patients with or...
Read More
Faster Thrombolytic Therapy Tied to Better All-Cause Stroke Outcomes at 12 Months
But door-to needle times not consistently associated with stroke recurrence Shorter door-to-needle...
Read More
Choosing Trial of Labor After Cesarean Not Aided By Decision Support Tool
PROCEED trial found tool did not out-perform usual care When women have had one Cesarean delivery,...
Read More
ASCO: Survival Benefit Emerges in ARAMIS
Darolutamide better in non-metastatic castration-resistant prostate cancer Men diagnosed with...
Read More
ASCO: Consultant Palliation Improves AML Quality of Life
Early referral linked to better psychological outcomes Referring a patient diagnosed with acute...
Read More